Altogether, these data suggest that loss of G0S2 expression (Figure 1A) promotes the blockade of differentiation observed in BP‐CML patients.63, 64. The gene discussed is G0S2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.